Raydiant Oximetry raises $7.5M in Series A3 extension round led by Cross-Border Impact Ventures (CBIV) to support clinical studies of Lumerah™ and Daisy™ technologies.
Amount Raised
$7.5 Million
Round Type
Series A
Investors
Description
Raydiant Oximetry, Inc. announced an oversubscribed $7.5 million Series A3 extension round led by Cross-Border Impact Ventures (CBIV) and syndicated by RH Capital, Global Health Impact Fund, VCapital, and the March of Dimes Innovation Fund. The funding will be used to support two clinical studies of the Lumerah™ and Daisy™ technologies, which aim to improve outcomes for mothers and babies during childbirth.
Quick answer
Raydiant Oximetry, Inc. raised $7.5 Million in a Series A round, dated June 4, 2024. Investors: Cross Border Impact Ventures, March Of Dimes Innovation Fund, V Capital, Global Health Impact Fund and RH Capital. Raydiant Oximetry, Inc. is based in San Ramon, California, United States.
- How much did Raydiant Oximetry, Inc. raise?
- Raydiant Oximetry, Inc. raised $7.5 Million in a Series A round on June 4, 2024.
- Who invested in Raydiant Oximetry, Inc?
- Cross Border Impact Ventures, March Of Dimes Innovation Fund, V Capital, Global Health Impact Fund and RH Capital are named as investors in this round.
- What does Raydiant Oximetry, Inc. do?
- Raydiant Oximetry, Inc. is a company dedicated to the mission of keeping mothers and babies safe during childbirth.
- Where is Raydiant Oximetry, Inc. based and how big is it?
- Raydiant Oximetry, Inc. is based in San Ramon, California, United States.
- Who are the decision-makers at Raydiant Oximetry, Inc?
- Fundz holds 1 contact at Raydiant Oximetry, Inc., including the Director. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Medical and Health Care around the same time
Companies in the same sectors as Raydiant Oximetry, Inc. that raised within 45 days of this round, from Fundz verified event records.
- Novocuff raised $26M (Series A) on July 17, 2024.
- Loci Orthopaedics raised $14M (Series A) on July 17, 2024.
- Huma Therapeutics raised $80M (Series D) on July 16, 2024.
- PulseMedica raised $12M (Pre-Series A) on July 16, 2024.
- Icanheal raised $1.8M (Seed) on July 16, 2024.
- Scorpion Therapeutics raised $150M (Series C) on July 16, 2024.
Who to call at Raydiant Oximetry, Inc., and when
A new round usually means Raydiant Oximetry, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Raydiant Oximetry, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Raydiant Oximetry, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Raydiant Oximetry, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Raydiant Oximetry, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansRaydiant Oximetry, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.